Journal of General Internal Medicine

, Volume 27, Issue 4, pp 452–457 | Cite as

Depression and Anxiety Diagnoses Are Not Associated with Delayed Resolution of Abnormal Mammograms and Pap Tests Among Vulnerable Women

  • Andrea C. Kronman
  • Karen M. Freund
  • Tim Heeren
  • Kristine A. Beaver
  • Mary Flynn
  • Tracy A. Battaglia
Original Research

Abstract

Background

Delays in care after abnormal cancer screening contribute to disparities in cancer outcomes. Women with psychiatric disorders are less likely to receive cancer screening and may also have delays in diagnostic resolution after an abnormal screening test.

Objective

To determine if depression and anxiety are associated with delays in resolution after abnormal mammograms and Pap tests in a vulnerable population of urban women.

Design

We conducted retrospective chart reviews of electronic medical records to identify women who had a diagnosis of depression or anxiety in the year prior to the abnormal mammogram or Pap test. We used time-to-event analysis to analyze the outcome of time to resolution after abnormal cancer screening, and Cox proportional hazards regression modeling to control for confounding.

Participants

Women receiving care in six Boston-area community health centers 2004–2005: 523 with abnormal mammograms, 474 with abnormal Pap tests.

Results

Of the women with abnormal mammogram and pap tests, 19% and 16%, respectively, had co-morbid depression. There was no difference in time to diagnostic resolution between depressed and not-depressed women for those with abnormal mammograms (aHR = 0.9, 95 CI 0.7,1.1) or Pap tests (aHR = 0.9, 95 CI 0.7,1.3).

Conclusions

An active diagnosis of depression and/or anxiety in the year prior to an abnormal mammogram or Pap test was not associated with a prolonged time to diagnostic resolution. Our findings imply that documented mood disorders do not identify an additional barrier to resolution after abnormal cancer screening in a vulnerable population of women.

KEY WORDS

depression cancer screening women’s health minority populations 

References

  1. 1.
    Charbonneau A, Rosen AK, Owen RR, et al. Monitoring depression care: in search of an accurate quality indicator. Medical Care. 2004;42:522–531.PubMedCrossRefGoogle Scholar
  2. 2.
    Pirraglia PASP, Singer DE, Ferris TG. Depressive symptom burden as a barrier to screening for breast and cervical cancers. J Womens Health. 2004;13:731–738.CrossRefGoogle Scholar
  3. 3.
    Jørgensen KJ. Mammography reduces breast cancer mortality in women aged 39–69 years; but harms may outweigh benefits in women under 50. Evid. Based Med. 2010;15:62–63.PubMedCrossRefGoogle Scholar
  4. 4.
    Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2009;151:727–737.PubMedGoogle Scholar
  5. 5.
    Lasser KE, Zeytinoglu H, Miller E, Becker AE, Hermann RC, Bor DH. Do women who screen positive for mental disorders in primary care have lower mammography rates? Gen. Hosp. Psychiatry. 2003;25:214–216.PubMedCrossRefGoogle Scholar
  6. 6.
    DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 2000;160:2101–2107.PubMedCrossRefGoogle Scholar
  7. 7.
    Pirraglia PA, Sanyal P, Singer DE, Ferris TG. Depressive symptom burden as a barrier to screening for breast and cervical cancers. J. Womens Health. 2004;13:731–738.CrossRefGoogle Scholar
  8. 8.
    Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J. Is the Promise of Cancer-Screening Programs Being Compromised? Quality of Follow-Up Care after Abnormal Screening Results. Med. Care Res. Rev. 2003;60:294–331.PubMedCrossRefGoogle Scholar
  9. 9.
    Bastani RYK, Myers RE, Glenn B. Interventions to improve follow-up of abnormal findings in cancer screening. Cancer. 2004;101:1188–1200.PubMedCrossRefGoogle Scholar
  10. 10.
    Breslau J, Kendler KS, Su M, Gaxiola-Aguilar S, Kessler RC. Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States. Psychol. Med. 2005;35:317–27.PubMedCrossRefGoogle Scholar
  11. 11.
    Cutrona C, Russell DW, Brown PA, Clark LA, Hessling RM, Gardner KA. Neighborhood context, personality, and stressful life events as predictors of depression among African American women. J. Abnorm. Psychol. 2005;114:3–15.PubMedCrossRefGoogle Scholar
  12. 12.
    Gwynn R, McQuistion HL, McVeigh KH, Garg RK, Frieden TR, Thorpe LE. Prevalence, diagnosis, and treatment of depression and generalized anxiety disorder in a diverse urban community. Psychiatr. Serv. 2008;59:641–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Lorant V, Deliège D, Eaton W, Robert A, Philippot P, Ansseau M. Socioeconomic inequalities in depression: a meta-analysis. Am. J. Epidemiol. 2003;157:98–112.PubMedCrossRefGoogle Scholar
  14. 14.
    Nejtek V, Brown ES, Khan DA, Moore JJ, Van Wagner J, Perantie DC. Prevalence of mood disorders and relationship to asthma severity in patients at an inner-city asthma clinic. Ann. Allergy Asthma Immunol. 2001;87:129–33.PubMedCrossRefGoogle Scholar
  15. 15.
    Pratt L, Brody DJ. Depression in the United States household population, 2005–2006. NCHS Data Brief. 2008:1–8.Google Scholar
  16. 16.
    Trupin L, Tonner MC, Yazdany J, et al. The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. J. Rheumatol. 2008;35:1782–8.PubMedGoogle Scholar
  17. 17.
    Compton W, Conway KP, Stinson FS, Grant BF. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991–1992 and 2001–2002. Am. J. Psychiatry. 2006;163:2141.PubMedCrossRefGoogle Scholar
  18. 18.
    Kessler R, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 1994;51:8–19.PubMedCrossRefGoogle Scholar
  19. 19.
    Battaglia TA, Santana CM, Bak S, et al. Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers. Cancer. 2010;116:913–921.PubMedCrossRefGoogle Scholar
  20. 20.
    Battaglia TA, Roloff K, Posner MA, et al. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007;109:359–367.PubMedCrossRefGoogle Scholar
  21. 21.
    Jones GNAS, Jeffries SK, Scarinci IC, Brantley PJ. Utilization of medical services and quality of life among low-income patients with generalized anxiety disorder attending primary care clinics. Int J Psychiatry Med. 2001;31:183–98.PubMedCrossRefGoogle Scholar
  22. 22.
    Fogarty CTSS, Chetty VK, Culpepper L. Mental health conditions are associated with increased health care utilization among urban family medicine patients. J. Am. Board Fam. Med. 2008;21:398–407.PubMedCrossRefGoogle Scholar
  23. 23.
    Weir H, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J. Natl. Cancer Inst. 2003;95:1276–1299.PubMedCrossRefGoogle Scholar
  24. 24.
    Kroenke KJ, Jackson JL, Chamberlin J. Depressive and anxiety disorders in patients presenting with physician complaints: clinical predictors and outcome. Am. J. Med. 1997;103:339–347Google Scholar
  25. 25.
    Aggarwal AFK, Sato A, Adams-Campbell LL, et al. Are depressive symptoms associated with cancer screening and cancer stage at diagnosis among postmenopausal women? The Women's Health Initiative observational cohort. J Womens Health. 2008;17:1353–1361.CrossRefGoogle Scholar
  26. 26.
    Patten SBWJ, Lavorato DH, Eliasziw M. The effect of major depression on participation in preventive health care activities. BMC Public Health. 2009;9:87.PubMedCrossRefGoogle Scholar
  27. 27.
    Calleo JSM, Greisinger A, Wehmanen O, et al. Generalized anxiety disorder in older medical patients: diagnostic recognition, mental health management and service utilization. J. Clin. Psychol. Med. Settings. 2009;16:178–185.PubMedCrossRefGoogle Scholar
  28. 28.
    Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann. Intern. Med. 2006;144:541–553.PubMedGoogle Scholar
  29. 29.
    Yabroff K, Breen N, Vernon SW, Meissner HI, Freedman AN, Ballard-Barbash R. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey. Cancer Epidemiol. Biomarkers Prev. 2004;13:723–732.PubMedGoogle Scholar
  30. 30.
    Ani CBM, Hindman D, Bell D, et al. Depression symptomatology and diagnosis: discordance between patients and physicians in primary care settings. MC Fam Pract. 2008;9(1):1.CrossRefGoogle Scholar
  31. 31.
    Simpson SM, Krishnan LL, Kunik ME, Ruiz P. Racial disparities in diagnosis and treatment of depression: a literature review. Psychiatr. Q. 2007;78(1):3–14.PubMedCrossRefGoogle Scholar
  32. 32.
    Harman JS, Schulberg HC, Mulsant BH, Reynolds CF. The effect of patient and visit characteristics on diagnosis of depression in primary care. J Fam Practice. 2001; 50(12).Google Scholar
  33. 33.
    Rawson NS, Malcolm E, D'Arcy C. Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psych Psych Epid. 1997;32(4):191–199.CrossRefGoogle Scholar
  34. 34.
    Hostetter AM, Egeland JA, Endicott J. Amish Study, II: Consensus diagnoses and reliability results. Ame J Psychiat. 1983;140(1):62–66.Google Scholar
  35. 35.
    Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–3105.PubMedCrossRefGoogle Scholar
  36. 36.
    Williams DR, Gonzalez HM, Neighbors H, et al. Prevalence and distribution of major depressive disorder in african americans, caribbean blacks, and non-hispanic whites: Results from the National Survey of American Life. Arch. Gen. Psychiatry. 2007;64(3):305–315.PubMedCrossRefGoogle Scholar
  37. 37.
    Valenstein M, Ritsema T, Green L, et al. Targeting quality improvement activities for depression. Implications of using administrative data. J Fam Practice. 2000;49(8):721–728.Google Scholar

Copyright information

© Society of General Internal Medicine 2011

Authors and Affiliations

  • Andrea C. Kronman
    • 1
  • Karen M. Freund
    • 1
  • Tim Heeren
    • 2
  • Kristine A. Beaver
    • 1
  • Mary Flynn
    • 1
  • Tracy A. Battaglia
    • 1
  1. 1.Women’s Health Unit, Section of General Internal Medicine, Department of Medicine, and Women’s Health Interdisciplinary Research CenterBoston University School of MedicineBostonUSA
  2. 2.Department of BiostatisticsBoston University School of Public HealthBostonUSA

Personalised recommendations